Controlling T cells via epigenetics

INSERM team proposes new autoimmune, immunodeficiency T cell targets in epigenetic pathway

An international academic team has discovered an epigenetic pathway that regulates CD4+ T cell differentiation and activity, and could yield new therapeutic targets for autoimmunity.

As drug developers seek the next generation of targeted therapies for autoimmune disease,

Read the full 370 word article

How to gain access

Continue reading with a
two-week free trial.